slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
17,1 TWD | 0,00% |
|
+0,88% | -17,39% |
Vakgebied
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Drug Genetic Testing
92,1
%
| 124 | 92,4 % | 122 | 92,1 % | -1,11% |
Other
5,7
%
| 6 | 4,2 % | 8 | 5,7 % | +35,10% |
Labor
2,2
%
| 4 | 3,4 % | 3 | 2,2 % | -36,47% |
Royalties
0,1
%
| 0 | 0,1 % | 0 | 0,1 % | -21,01% |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Taiwan
87,7
%
| 119 | 89,3 % | 116 | 87,7 % | -2,57% |
Asia
9,8
%
| 10 | 7,1 % | 13 | 9,8 % | +36,90% |
America
2,1
%
| 1 | 0,8 % | 3 | 2,1 % | +157,58% |
Europe
0,4
%
| 4 | 2,8 % | 1 | 0,4 % | -85,58% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Fu Hui Chan
CEO | Chief Executive Officer | - | 04-11-19 |
Kuan Chih Chen
COO | Chief Operating Officer | - | 04-11-19 |
Wu Jung Hsieh
AUD | Comptroller/Controller/Auditor | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yi Hsiung Chen
BRD | Director/Board Member | - | 24-11-20 |
Chun Chi Chiang
BRD | Director/Board Member | - | - |
Fu Hui Chan
CEO | Chief Executive Officer | - | 04-11-19 |
Tse Hsiao
BRD | Director/Board Member | - | 04-11-19 |
Chin Tse Chen
BRD | Director/Board Member | - | 04-11-19 |
Ying Chou Hsu
BRD | Director/Board Member | - | 07-08-20 |
Ying Ta Li
BRD | Director/Board Member | - | 07-08-20 |
Chun Yi Li
BRD | Director/Board Member | - | 23-06-20 |
Chih Ping Chen
BRD | Director/Board Member | - | 24-11-20 |
Yi Jou Chen
BRD | Director/Board Member | - | 24-11-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 50 465 000 | 24 875 020 ( 49,29 %) | 0 | 49,29 % |
Bedrijfsgegevens
![Adres Pharmigene, Inc.(7595)](https://cdn.zonebourse.com/static/address/119075178.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-17,39% | 26,65 mln. | |
-43,39% | 7,89 mld. | |
+11,68% | 3,86 mld. | |
-21,21% | 2 mld. | |
-23,77% | 1,67 mld. | |
+14,81% | 1,03 mld. | |
+18,25% | 761 mln. | |
-10,04% | 693 mln. | |
-36,12% | 486 mln. | |
-4,47% | 266 mln. |
- Beurs
- Aandelen
- Koers 7595
- Onderneming Pharmigene, Inc.